Proliferative Diabetic Retinopathy Requiring Vitrectomy Over Clinic Management During COVID-19: Impact of Delayed

Bennett E Ahearn1, Huy Nguyen1, Jeong-Hyeon Sohn1

  • 1Department of Ophthalmology, University of Texas Health San Antonio, San Antonio, TX, USA.

Insights

Delayed clinical care for proliferative diabetic retinopathy (PDR) during the COVID-19 pandemic increased the likelihood of vitrectomy. Patient-driven appointment rescheduling was the primary cause of these delays, underscoring the need for consistent follow-up.

Area of Science:

  • Ophthalmology
  • Diabetology
  • Public Health

Background:

  • The COVID-19 pandemic disrupted routine clinical care, potentially impacting chronic disease management.
  • Proliferative diabetic retinopathy (PDR) requires consistent monitoring to prevent vision-threatening complications.

Purpose of the Study:

  • To investigate how delayed retinal clinical care during the COVID-19 pandemic affected PDR severity.
  • To identify factors contributing to follow-up delays and the need for vitrectomy in PDR patients.

Main Methods:

  • A cohort of 739 PDR patients diagnosed between 2018 and 2021 were analyzed.
  • Patients were categorized into vitrectomy and non-vitrectomy groups.
  • Multivariate regression assessed factors influencing vitrectomy, including disease staging, progression, and appointment adherence.

Main Results:

  • 202 patients (27.3%) required vitrectomy, often presenting with more severe or unstable disease.
  • Both groups experienced increased appointment intervals post-pandemic, with a greater increase in the vitrectomy group.
  • Patient-directed rescheduling was the primary driver of appointment delays.

Conclusions:

  • More severe PDR and appointment delays during the pandemic correlated with increased need for vitrectomy.
  • Maintaining regular follow-up for PDR patients is crucial, especially during public health crises.
  • Patient-initiated rescheduling significantly impacts care continuity.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
491
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
578
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
633